Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The study aims to study the outcome of pharmacokinetics-adjusted dose ribavirin (plus pegIFN) on the SVR in chronic HCV patients.
Epistemonikos ID: 1cf0d47d9cad00512cf13af448689afc84dd6489
First added on: Mar 23, 2020